DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Companies / Rightway Healthcare, Inc.
Rightway Healthcare, Inc.
Stage unknownNew York, NYOther Health Care
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 1
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 1
Financing history
1 rounds
- Mar 25, 2024Form D equity offering · $109M (form d sold) · 14 investorsFact SEC EDGAR Form D data sets (quarterly) · “Rightway Healthcare, Inc. filed Form D: $108,749,915 sold (indefinite offering), Other Health Care”
Investors on record
1 edges
- Khosla Ventures, LLC board only, Samir Kaul (strongly supported) Inference sec.gov
People
2 officers, 5 directors
- Jordan Feldman Executive Officer/Director sec.gov
- Theodore Feldman Executive Officer/Director sec.gov
- Kareem Zaki Director Fact
- Michael Lynton Director Fact
- Samir Kaul Director Fact
- Samir Kaul Director Inference
- Jonathan Locker Director Fact
Timeline
1
- Mar 29, 2024Rightway Healthcare, Inc. filed Form D: $108,749,915 sold (indefinite offering), Other Health CareForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
14 observations
Every observation on this company
- Entity type: Corporation Mar 29, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Other Health Care Mar 29, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Mar 29, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Mar 29, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: overFiveYears Mar 29, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Mar 29, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $109M Mar 29, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Mar 29, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2024-03-25 Mar 29, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Indefinite offering: true Mar 29, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 14 Mar 29, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Mar 29, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity Mar 29, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 2 Gansevoort Street, NEW YORK, NY, 10014 Mar 29, 2024 Fact SEC EDGAR Form D data sets (quarterly)